MagBiosense (LLC) is a private medical device company focused on the development of breakthrough diagnostic device & assays, offering laboratory-quality sensitivity and the rapid results and ease of use of a point-of-care system. The company’s core technology eliminates the need for additional steps in the detection process, thereby allowing a simple, one-step process in a point-of-care setting. Using high sensitivity detection of cardiac biomarkers, MagBiosense is initially focusing its development on rapid diagnosis and rule out of heart attack at the Emergency Department.